C-ABL-IN-3 - CAS 2626934-64-1

C-ABL-IN-3, a highly effective c-Abl inhibitor, exhibits promising potential for studying neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), as well as cancer [1]. The activation of c-Abl has been strongly implicated in a range of diseases, notably cancer [1]. It offers valuable opportunities for research in these fields [1].

Others, Bcr-Abl

Angiogenesis, Others, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors

2626869

C17H11F3N4O3

376.29

O=C1N(C=C(C(NC2=CC=C(OC(F)(F)F)C=C2)=O)C=C1)C=3C=NC=NC3

-20°C

Ice Packs

Small Compound